Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.

Rombaut D, Sandmann S, Tekath T, Crouch S, de Graaf AO, Smith A, Painter D, Kosmider O, Tobiasson M, Lennartsson A, van der Reijden BA, Park S, D'Aveni M, Slama B, Clappier E, Fenaux P, Adès L, van de Loosdrecht A, Langemeijer S, Symeonidis A, Čermák J, Preudhomme C, Savic A, Germing U, Stauder R, Bowen D, van Marrewijk C, Bernard E, de Witte T, Varghese J, Hellström-Lindberg E, Dugas M, Martens J, Malcovati L, Jansen JH, Fontenay M, MDS‐RIGHT consortium

Open source

DOI
10.1002/hem3.70073
Published
2025 Jan
Container
HemaSphere
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hem3.70073,
  title = {Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.},
  author = {Rombaut D and Sandmann S and Tekath T and Crouch S and de Graaf AO and Smith A and Painter D and Kosmider O and Tobiasson M and Lennartsson A and van der Reijden BA and Park S and D'Aveni M and Slama B and Clappier E and Fenaux P and Adès L and van de Loosdrecht A and Langemeijer S and Symeonidis A and Čermák J and Preudhomme C and Savic A and Germing U and Stauder R and Bowen D and van Marrewijk C and Bernard E and de Witte T and Varghese J and Hellström-Lindberg E and Dugas M and Martens J and Malcovati L and Jansen JH and Fontenay M and MDS‐RIGHT consortium},
  year = {2025},
  journal = {HemaSphere},
  doi = {10.1002/hem3.70073},
  url = {https://doi.org/10.1002/hem3.70073}
}

RIS

TY  - JOUR
TI  - Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.
AU  - Rombaut D
AU  - Sandmann S
AU  - Tekath T
AU  - Crouch S
AU  - de Graaf AO
AU  - Smith A
AU  - Painter D
AU  - Kosmider O
AU  - Tobiasson M
AU  - Lennartsson A
AU  - van der Reijden BA
AU  - Park S
AU  - D'Aveni M
AU  - Slama B
AU  - Clappier E
AU  - Fenaux P
AU  - Adès L
AU  - van de Loosdrecht A
AU  - Langemeijer S
AU  - Symeonidis A
AU  - Čermák J
AU  - Preudhomme C
AU  - Savic A
AU  - Germing U
AU  - Stauder R
AU  - Bowen D
AU  - van Marrewijk C
AU  - Bernard E
AU  - de Witte T
AU  - Varghese J
AU  - Hellström-Lindberg E
AU  - Dugas M
AU  - Martens J
AU  - Malcovati L
AU  - Jansen JH
AU  - Fontenay M
AU  - MDS‐RIGHT consortium
PY  - 2025
JO  - HemaSphere
DO  - 10.1002/hem3.70073
UR  - https://doi.org/10.1002/hem3.70073
ER  - 

APA

D, R., S, S., T, T., S, C., AO, D. G., A, S., D, P., O, K., M, T., A, L., BA, V. D. R., S, P., M, D., B, S., E, C., P, F., L, A., A, V. D. L., S, L., A, S., J, Č., C, P., A, S., U, G., R, S., D, B., C, V. M., E, B., T, D. W., J, V., E, H., M, D., J, M., L, M., JH, J., M, F., & consortium, M. (2025). Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.. HemaSphere. https://doi.org/10.1002/hem3.70073

Source records